17β-Hydroxysteroid Dehydrogenase-3 Deficiency: Diagnosis, Phenotypic Variability, Population Genetics, and Worldwide Distribution of Ancient and de Novo Mutations1
Annemie L. M. Boehmer(Erasmus MC - Sophia Children’s Hospital), Stenvert L. S. Drop(Erasmus MC - Sophia Children’s Hospital), Dicky Halley(Norwegian Institute for Nature Research), Hülya Kayserili(Istanbul University), Lodewijk A. Sandkuijl, Cidade Rodrigues(Hospital Maria Pia), Albert O. Brinkmann(Erasmus University Rotterdam), Petra E. de Ruiter(Erasmus University Rotterdam), Monique A. de Vroede(Wilhelmina Children's Hospital), Frank H. de Jong(Uppsala University Hospital), Hans H. Bode(Sydney Children's Hospital), Martinus F. Niermeijer(Rotterdam University of Applied Sciences), Stefan Andersson(Uppsala University), Barto J. Otten, Berenice B. Mendonça(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Henriëtte A. Delemarre‐van de Waal(University of Amsterdam), Catrienus W. Rouwé
Cited by 177
Related Papers
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
|Cell|2000|1.6k
Serum antimüllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal study
|Fertility and Sterility|2005|582
Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3
|Nature Genetics|1994|574
A <i>GPR54</i> -Activating Mutation in a Patient with Central Precocious Puberty
|New England Journal of Medicine|2008|566